Browse drugs

…in 4 (17.4%), 7 (28.0%) and 11 (40.7%) patients in the placebo, nerandomilast 9 mg and 18 mg BID groups, respectively. Rates of treatment dis…

…most frequent reason for admission was intravenous therapy with rituximab (62.5%), as well as complications such as digital ulcers (25%, …

…nt systemic treatment in both LS (67.9%) and SSc (48%). In SSc, mycophenolate mofetil (38.1%) and cyclophosphamide (14.1%) were also commonly used. B…

…es ANA, anti-Sm and anti-RO 52 were positive. Antimalarials and prednisone were started. One year later, her physical examination showed d…

…esponse was achieved with oral corticosteroids, cyclosporin and Rituximab, almost no response was obtained with MMF and MTX.Owing to the …

…ac involvement was treated with CTX (CYCLOPS Regime) along with prednisone 40 mg.Both cases were closely monitored for their BP and renal …

…SLE, resulting in prolonged corticosteroid dependence. Although rituximab was initially tolerated and achieved disease stability, relapse…

…balances and neurodegenerative conditions were ruled out. After levofloxacin was discontinued, the patient’s symptoms improved rapidly, and …

…n T1D pathogenesis, including therapeutic B cell depletion with rituximab, which preserved beta-cell function for 1 year,38 and variation…

…atified according to anti-SS-A antibody status, and response to tocilizumab (TCZ) or rituximab (RTX) was evaluated.Results Among 212 cases,…

…y with axicabtagene ciloleucel (axi-cel). Bridging therapy with polatuzumab plus rituximab, followed by Axi-cel infusion after a standard l…

…enous immunoglobulin response was generally poor, while delayed rituximab initiation still led to clinical improvement in the juvenile-on…